Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.

Espinel-Ingroff A, Kish CW Jr, Kerkering TM, Fromtling RA, Bartizal K, Galgiani JN, Villareal K, Pfaller MA, Gerarden T, Rinaldi MG, et al.

J Clin Microbiol. 1992 Dec;30(12):3138-45.

2.

Candida zeylanoides: another opportunistic yeast.

Levenson D, Pfaller MA, Smith MA, Hollis R, Gerarden T, Tucci CB, Isenberg HD.

J Clin Microbiol. 1991 Aug;29(8):1689-92.

3.
4.

Susceptibility of clinical isolates of Candida spp. to terconazole and other azole antifungal agents.

Pfaller MA, Gerarden T.

Diagn Microbiol Infect Dis. 1989 Nov-Dec;12(6):467-71.

PMID:
2696620
5.

Value of the Cand-Tec Candida antigen assay in the diagnosis and therapy of systemic candidiasis in high-risk patients.

Cabezudo I, Pfaller M, Gerarden T, Koontz F, Wenzel R, Gingrich R, Heckman K, Burns CP.

Eur J Clin Microbiol Infect Dis. 1989 Sep;8(9):770-7.

PMID:
2512147
6.

Fungicidal activity of cilofungin (LY121019) alone and in combination with anticapsin or other antifungal agents.

Pfaller M, Gordee R, Gerarden T, Yu M, Wenzel R.

Eur J Clin Microbiol Infect Dis. 1989 Jun;8(6):564-7.

PMID:
2504601
7.

Susceptibility of nosocomial isolates of Candida species to LY121019 and other antifungal agents.

Pfaller MA, Wey S, Gerarden T, Houston A, Wenzel RP.

Diagn Microbiol Infect Dis. 1989 Jan-Feb;12(1):1-4.

PMID:
2714066
8.

Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019.

Pfaller MA, Gerarden T, Yu M, Wenzel RP.

Diagn Microbiol Infect Dis. 1988 Sep;11(1):1-9.

PMID:
3219817
9.
10.

The use of the Prompt Inoculation System in preparing a standardized yeast inoculum.

Pfaller MA, Gerarden T.

Am J Clin Pathol. 1987 Dec;88(6):743-5.

PMID:
3318388
11.

Supplemental Content

Loading ...
Support Center